Trump's Budget Blueprint: Cosmetics Opportunity Or Unhelpful Distraction?
This article was originally published in The Rose Sheet
Executive Summary
President Trump appears to want greater user-fee contributions from FDA-regulated industries to offset cuts to federal spending in fiscal 2018. His recently released budget blueprint could complicate negotiations that cosmetics stakeholders were hoping to join, but it also could signal opportunity for an industry seeking increased regulation – and willing to pay for it.
You may also be interested in...
Trump's Budget Surprise: FDA Gets 13% Increase
President Trump's FY 2019 budget request includes $473m in new non-user fee revenue for the US agency, a reversal of the previous year's request.
Gottlieb Becomes FDA Commissioner With Immediate Issues Pending
Confirmation comes with fewest votes of any recent commissioner as FDA faces pressing budget, user-fee and other issues. The Personal Care Products Council welcomed Gottlieb to the post and took the occasion to plug cosmetics industry virtues at a time when legislation is under consideration to update regulations.
FDA Gains Budget Increase In FY 2017 … And Not Through Fees
Omnibus legislation to fund the federal government for FY 2017 includes an increase in non-user fee funds, which should please stakeholders.